Abstract
Intervertebral disc (IVD) degeneration and associated low back pain (LBP) remains a major burden to our society without significant improvements in treatment strategies or patient’s quality of life. While the recent cell-transplantation studies for treatment of degenerative disc disease have shown promising results, to better gauge the success and functional outcomes of these therapies, it is crucial to understand if transplanted cells give rise to healthy nucleus pulposus (NP) tissue. NP cell phenotype is unique and is defined by expression of a characteristic set of markers that reflect specialized physiology and function. This review summarizes phenotypic markers that mirror the unique physiology and function of NP cells and their progenitors and should be considered to when measuring outcomes of cell-based therapies to treat disc degeneration.
Keywords: Annulus fibrosus, cell phenotype, hypoxia, intervertebral disc degeneration, intervertebral disc, nucleus pulposus, stem cell therapy.
Current Stem Cell Research & Therapy
Title:Understanding Nucleus Pulposus Cell Phenotype: A Prerequisite for Stem Cell Based Therapies to Treat Intervertebral Disc Degeneration
Volume: 10 Issue: 4
Author(s): Hyowon Choi, Zariel I. Johnson and Makarand V. Risbud
Affiliation:
Keywords: Annulus fibrosus, cell phenotype, hypoxia, intervertebral disc degeneration, intervertebral disc, nucleus pulposus, stem cell therapy.
Abstract: Intervertebral disc (IVD) degeneration and associated low back pain (LBP) remains a major burden to our society without significant improvements in treatment strategies or patient’s quality of life. While the recent cell-transplantation studies for treatment of degenerative disc disease have shown promising results, to better gauge the success and functional outcomes of these therapies, it is crucial to understand if transplanted cells give rise to healthy nucleus pulposus (NP) tissue. NP cell phenotype is unique and is defined by expression of a characteristic set of markers that reflect specialized physiology and function. This review summarizes phenotypic markers that mirror the unique physiology and function of NP cells and their progenitors and should be considered to when measuring outcomes of cell-based therapies to treat disc degeneration.
Export Options
About this article
Cite this article as:
Choi Hyowon, Johnson I. Zariel and Risbud V. Makarand, Understanding Nucleus Pulposus Cell Phenotype: A Prerequisite for Stem Cell Based Therapies to Treat Intervertebral Disc Degeneration, Current Stem Cell Research & Therapy 2015; 10 (4) . https://dx.doi.org/10.2174/1574888X10666150113112149
DOI https://dx.doi.org/10.2174/1574888X10666150113112149 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia
Current Molecular Medicine Surgical Treatment of Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension
Current Pharmaceutical Design Endogenous Enzyme-responsive Nanoplatforms for Anti-tumor Therapy
Current Drug Targets Terpenoids: Sources, Structure Elucidation and Therapeutic Potential in Inflammation
Current Topics in Medicinal Chemistry Developments in Thermometry from 1984 to 2011: A Review
Recent Patents on Mechanical Engineering Patent Selections
Recent Patents on Food, Nutrition & Agriculture Parallel Computing for Brain Simulation
Current Topics in Medicinal Chemistry Mitochondria-Targeted Antioxidant Peptide SS31 Protects the Retinas of Diabetic Rats
Current Molecular Medicine Giardiasis in the Post Genomic Era: Treatment, Drug Resistance and Novel Therapeutic Perspectives
Infectious Disorders - Drug Targets Contemporary Animal Models For Human Gene Therapy Applications
Current Gene Therapy Controversies in the Use of Nutritional Supplements in Ophthalmology
Current Pharmaceutical Design Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia
Current Neurovascular Research Expression of mTOR/70S6K Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin
Current Cancer Therapy Reviews Recent Inventions on Receptor Tyrosine Kinase RET Modulation
Recent Patents on Biotechnology Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview
Current Pharmaceutical Design Mitochondrial Dysfunction in Huntington’s Disease: Pathogenesis and Therapeutic Opportunities
Current Drug Targets PEDF in Angiogenic Eye Diseases
Current Molecular Medicine MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Recent Patents on Biomarkers Ketogenic Diets in the Treatment of Epilepsy
Current Pharmaceutical Design Microwave-Assisted Multicomponent Reactions in the Heterocyclic Chemistry
Current Organic Chemistry